Peer-reviewed articleOpen access

Editorial: Glutamatergic system in affective and psychotic disorders: pre-clinical and clinical advances.

Strzelecki D iD, Talarowska M, Kaźmierski J iD, Waszkiewicz N, Curtis D

Frontiers in neuroscienceJan 9, 2024License: open accessPoland, United Kingdom0 citationsDOI: 10.3389/fnins.2023.1358271

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

SchizophreniaSarcosineAffective DisordersGlutamatergic SystemGabaergic SystemEsketamine

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Chemsex drugs: More than ghb, mephedrone and methamphetamine?

Ramos J, Dolengevich H, Romerosa M +1

Europe PMC2021

ArticleKetamine

Midazolam-Ketamine (MK) Versus Propofol-Ketamine (PK) for Pediatric Burn Patients Undergoing Dressing Changes: A Non-Randomized Cross-Over Clinical Trial.

Guellim S, Hamada HB, Bouji N +4

Europe PMC2025

ArticleKetamine

Efficacy and safety comparison of esketamine-propofol with nalbuphine-propofol for upper gastrointestinal endoscopy in children: a multi-center randomized controlled trial.

Zheng X, Huang J, Wei S +6

Europe PMC2023